BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31759867)

  • 1. ABCB4 disease: Many faces of one gene deficiency.
    Sticova E; Jirsa M
    Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
    Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
    J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
    Reichert MC; Lammert F
    Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the mutational spectrum of the ABCB4 gene in inherited adult cholestatic liver disorders with four novel pathogenic variants.
    Huynh MT; Delaunay JL; Muller L; Corpechot C; Tran CT; Barbu V
    Rev Esp Enferm Dig; 2019 Jan; 111(1):76-79. PubMed ID: 30449124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
    Pasmant E; Goussard P; Baranes L; Laurendeau I; Quentin S; Ponsot P; Consigny Y; Farges O; Condat B; Vidaud D; Vidaud M; Chen JM; Parfait B
    Eur J Hum Genet; 2012 Mar; 20(3):277-82. PubMed ID: 21989363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
    Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
    Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The wide phenotypic and genetic spectrum of ABCB4 gene deficiency: A case series.
    Falcão D; Pedroto I; Moreira T
    Dig Liver Dis; 2022 Feb; 54(2):221-227. PubMed ID: 34376370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low phospholipid-associated cholestasis and cholelithiasis.
    Erlinger S
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S36-40. PubMed ID: 23141892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.
    Goubran M; Aderibigbe A; Jacquemin E; Guettier C; Girgis S; Bain V; Mason AL
    BMC Med Genet; 2020 Nov; 21(1):238. PubMed ID: 33256620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
    Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
    J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1.
    Nayagam JS; Williamson C; Joshi D; Thompson RJ
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1628-1639. PubMed ID: 33070363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
    Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X
    BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
    Jacquemin E; De Vree JM; Cresteil D; Sokal EM; Sturm E; Dumont M; Scheffer GL; Paul M; Burdelski M; Bosma PJ; Bernard O; Hadchouel M; Elferink RP
    Gastroenterology; 2001 May; 120(6):1448-58. PubMed ID: 11313315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations.
    Fang LJ; Wang XH; Knisely AS; Yu H; Lu Y; Liu LY; Wang JS
    J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):150-6. PubMed ID: 22343912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Phospholipid Associated Cholelithiasis (LPAC) syndrome: A synthetic review.
    Goubault P; Brunel T; Rode A; Bancel B; Mohkam K; Mabrut JY
    J Visc Surg; 2019 Sep; 156(4):319-328. PubMed ID: 30922600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
    Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
    Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCB4/MDR3 in health and disease - at the crossroads of biochemistry and medicine.
    Prescher M; Kroll T; Schmitt L
    Biol Chem; 2019 Sep; 400(10):1245-1259. PubMed ID: 30730833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver diseases related to MDR3 (ABCB4) gene deficiency.
    Gonzales E; Davit-Spraul A; Baussan C; Buffet C; Maurice M; Jacquemin E
    Front Biosci (Landmark Ed); 2009 Jan; 14(11):4242-56. PubMed ID: 19273348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications.
    Yeap SP; Harley H; Thompson R; Williamson KD; Bate J; Sethna F; Farrell G; Hague WB
    J Gastroenterol Hepatol; 2019 Feb; 34(2):425-435. PubMed ID: 29992621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
    Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
    J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.